Columbia Asset Management Abb Vie Inc. Transaction History

Columbia Asset Management

$493 Million
Q1 2024

A detailed history of Columbia Asset Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Columbia Asset Management holds 40,365 shares of ABBV stock, worth $6.78 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

40,365

Previous 40,365 -0.0%

Holding current value

$6.78 Million

Previous $6.26 Million -0.0%

% of portfolio

1.27%

Previous 1.27%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $9,769 - $11,002	-71 Reduced 0.18%	40,365 $6.26 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $48,893 - $56,601	-366 Reduced 0.9%	40,436 $6.03 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $726,684 - $904,311	-5,484 Reduced 11.85%	40,802 $5.5 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $124,943 - $143,890	-864 Reduced 1.83%	46,286 $7.38 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $36,652 - $43,955	-265 Reduced 0.56%	47,150 $7.62 Million

Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $166,823 - $191,334	-1,243 Reduced 2.55%	47,415 $6.36 Million
Q2 2022 Aug 26, 2022	SELL	$137.62 - $174.96 $957,147 - $1.22 Million	-6,955 Reduced 12.51%	48,658 $7.45 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $47,806 - $60,488	445 Added 0.81%	55,613 $7.53 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $83,098 - $94,329	781 Added 1.44%	55,168 $5.95 Million
Q2 2021 Aug 02, 2021	SELL	$105.21 - $117.21 $814,325 - $907,205	-7,740 Reduced 12.46%	54,387 $6.13 Million
Q1 2021 May 28, 2021	BUY	$102.3 - $112.62 $600,194 - $660,741	5,867 Added 10.43%	62,127 $6.72 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $92,965 - $125,513	1,155 Added 2.1%	56,260 $6.03 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $96,992 - $113,837	-1,129 Reduced 2.01%	55,105 $4.83 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $3.28 Million - $4.38 Million	-44,655 Reduced 44.26%	56,234 $5.52 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $3.32 Million - $5.03 Million	51,440 Added 104.03%	100,889 $47.7 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $173,256 - $216,780	2,402 Added 5.11%	49,449 $43.8 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $216,651 - $260,476	3,440 Added 7.89%	47,047 $3.56 Million
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $472,448 - $603,900	7,191 Added 19.75%	43,607 $3.17 Million
Q1 2019 May 20, 2019	BUY	$77.14 - $90.79 $139,391 - $164,057	1,807 Added 5.22%	36,416 $2.94 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $106,265 - $131,053	1,365 Added 4.11%	34,609 $3.19 Million
Q3 2018 Nov 06, 2018	BUY	$88.91 - $98.84 $50,767 - $56,437	571 Added 1.75%	33,244 $3.14 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $267,813 - $316,884	2,983 Added 10.05%	32,673 $3.03 Million
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $18,862 - $25,258	-205 Reduced 0.69%	29,690 $2.81 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $47,019 - $51,560	-525 Reduced 1.73%	29,895 $2.89 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $2.12 Million - $2.71 Million	30,420	30,420 $2.7 Million

Others Institutions Holding ABBV

# of Institutions

3,657

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Asset Management with notifications on news.

Account

Columbia Asset Management Abb Vie Inc. Transaction History